Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-21-014843)

Filing Details

Accession Number:: 0000899243-21-014843
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-05 16:37:12
Reporting Period:: 2021-02-11

Accepted Time:: 2021-04-05 16:37:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1665988	Bioventus Inc.	BVS	Surgical & Medical Instruments & Apparatus (3841)	810980861

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1835184	Anthony D'adamio	4721 Emperor Boulevard, Suite 100 Durham NC 27703	Svp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-02-11	1,000	$13.00	1,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Restricted Stock Units	Acquisiton	2021-04-01	37,476	$0.00	37,476	$0.00
Class A Common Stock	Stock Options	Acquisiton	2021-04-01	9,500	$0.00	9,500	$15.23

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
37,476			No	4	A	Direct
9,500		2031-03-31	No	4	A	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The restricted stock units vest on April 1, 2022 and have no expiration date.
The stock option vests in four equal annual installments beginning on April 1, 2022.